Mentalization-Based Treatment for BPD: How MBT Works and Evidence
Author: Ukrainian Psychological Hub · Published: October 12, 2026 · Editorial Policy
Mentalization-based treatment (MBT) is a structured psychotherapy developed to help people with borderline personality disorder (BPD) understand their own emotional states and interpret other people's behavior with greater flexibility, especially when relationships become stressful. The treatment focuses on mentalizing: making sense of feelings, intentions, beliefs, wishes, and misunderstandings while recognizing that another person's mind cannot be known with certainty. MBT usually combines individual and group psychotherapy within a coordinated clinical program. Its central therapeutic aim is to restore reflective thinking when intense emotion makes interpersonal situations difficult to understand.
Clinical research supports MBT as a reasonable, evidence-informed treatment option for BPD, although confidence in its comparative effects is limited. Some randomized trials report reductions in symptoms, crises, or self-harm relative to comparison care; other trials find similar outcomes across different well-organized treatments. A 2025 review of 14 randomized trials judged all included trials to be at high risk of bias. The American Psychiatric Association's 2024 practice guideline recommends a supported, structured psychotherapy for BPD, selected through collaborative, person-centered treatment planning.
What is mentalization-based treatment for borderline personality disorder?
MBT is a manual-informed form of psychotherapy organized around the relationship between emotion, attachment, interpersonal interpretation, and behavior. It was developed by Anthony Bateman and Peter Fonagy, initially in a partial-hospitalization setting and later in outpatient formats. In practice, the therapist helps the person investigate what happened during an emotionally important encounter, what each participant may have felt or intended, and when an interpretation became too certain or ceased to account for other possibilities. The original outpatient program was tested over 18 months in a randomized study of 134 adults with BPD. Bateman and Fonagy, 2009.
MBT is used in the treatment of a clinically evaluated condition, not as a diagnostic test. BPD involves characteristic difficulties that may include affective instability, interpersonal sensitivity, identity disturbance, impulsivity, or recurrent crises, with substantial variation between people and across time. A person can struggle to understand another's intentions, become overwhelmed during conflict, or misread a message without having BPD. Those experiences, alone or together, establish neither a mental disorder nor the need for MBT. For diagnostic context, see Borderline Personality Disorder: Symptoms, Diagnosis, and Treatment.
What does mentalizing mean in MBT?
Mentalizing is the capacity to understand behavior in relation to possible mental states. It includes recognizing feelings within oneself, noticing what might be happening in another person, and revising assumptions when new evidence appears. Mental states are inferred, not directly observed. Effective mentalizing therefore combines curiosity about other people with awareness of one's own emotional experience and willingness to be mistaken. It is relevant to ordinary relationships as well as clinical care, and it fluctuates according to stress, exhaustion, conflict, familiarity, and context.
For example, imagine sending a friend a personal message and receiving a short reply. One interpretation is, 'They are angry with me.' Other explanations include distraction, limited time, fatigue, or misunderstanding. Mentalizing involves noticing the first interpretation, identifying the feelings it activates, and allowing a reasonable range of possibilities before deciding what to do. In a tense relationship the interpretive process can become much faster and more rigid. MBT works directly with such moments without asking the person to deny genuine distress.
Mentalizing oneself and other people
Therapists attend to both self-focused and other-focused understanding. A person may recognize that they are frightened but struggle to describe what triggered that fear; they may accurately notice another person's frustration yet assume it has only one cause. MBT helps develop a more coherent account of emotional experience while leaving room for alternative explanations of someone else's behavior. A related clinical goal is to identify when powerful interpretations of another's intentions have become detached from available evidence.
Automatic and deliberate mentalizing
Some social understanding happens quickly and almost automatically, as when a familiar facial expression signals concern. Deliberate mentalizing becomes useful when an encounter is ambiguous or emotionally charged. Under pressure, an immediate interpretation can dominate thought before the person has considered its basis. MBT slows the process sufficiently to notice what is known, what is assumed, and what further conversation might clarify. This is a therapeutic model of change; precisely how much improvement in mentalizing mediates clinical recovery remains an active research question. Vogt and Norman, 2019.
Feelings, thoughts, and the limits of certainty
MBT pays attention to emotional and cognitive aspects of understanding: sensing the intensity of anger or shame, identifying beliefs about why another person acted as they did, and appreciating how two people can experience the same event differently. Neither an apparently calm account nor an emotionally vivid account guarantees accuracy. The useful skill is a balanced inquiry that respects feeling while evaluating interpretation. This also helps distinguish a person's inner intention from the outward impact of their behavior.
Why is mentalizing relevant to BPD?
MBT's central clinical hypothesis is that intense attachment-related arousal can disrupt reflective understanding in people who already experience difficulties regulating relationships or emotions. A disagreement with someone important may be followed by fear of abandonment, an abrupt conclusion about the other person's motives, intense anger, or urgent action. These reactions can then alter the relationship, creating additional uncertainty and stress. MBT addresses the process in which interpretation, emotion, and action reinforce one another.
This account is a treatment formulation, not a complete or proven explanation of the causes of BPD. Developmental experience, temperament, social context, genetic liability, adversity, and current circumstances may all matter. Trauma is important for some people, but a particular traumatic history is neither required to diagnose BPD nor sufficient to explain every person's presentation. Therapists should assess the person's history and needs rather than automatically impose one attachment narrative. The 2025 review emphasizes that research has not adequately represented differences in severity, comorbidity, and developmental stage.
What happens during MBT sessions?
Initial assessment, agreement, and shared goals
A structured program begins with a comprehensive clinical assessment and shared treatment plan. Clinicians clarify the person's central difficulties, current safety concerns, relationship patterns, co-occurring conditions, treatment preferences, resources, and realistic goals. Goals may involve reducing destabilizing interpersonal conflict, strengthening the ability to remain in a difficult conversation, understanding abrupt emotional shifts, maintaining work or study, and responding more safely during crises. As the APA guideline recommends, assessment and planning should be comprehensive, collaborative, and person-centered.
The clinician may offer a formulation describing situations in which mentalizing becomes difficult. For example, feelings of exclusion may make the person interpret a late reply as deliberate rejection; this may lead to withdrawal or an angry message, which then changes the relationship. The formulation is an evolving map for treatment, and its accuracy is tested with the person rather than treated as a fixed truth.
Individual psychotherapy
Individual MBT often begins with an emotionally meaningful incident from the preceding week. The therapist invites the person to describe what occurred, what they noticed in their body and emotions, what they believed another person meant, and what happened next. The discussion may move slowly through a brief sequence rather than immediately seeking a broad explanation. When the person becomes overwhelmed, the therapist may shift attention to the present emotional state or pause the inquiry until reflective conversation is possible.
The therapist also examines misunderstandings within the therapeutic relationship. A missed appointment, perceived criticism, an unexpected silence, or a change in the session can evoke powerful assumptions. These moments provide opportunities to explore different perspectives with care. A good intervention respects the actual experience of distress and the possibility that the therapist contributed to the misunderstanding.
Group psychotherapy
Many established outpatient MBT programs use weekly group sessions alongside individual meetings. Groups provide a real setting for observing how several people understand the same interaction differently, noticing changing emotional states, and repairing misunderstandings. The therapist guides discussion so that participants can reflect on intentions without turning the group into a forum for judging who is right. Clear boundaries, confidentiality, preparation, and attention to safety are important. Group therapy can feel intimidating initially, especially for people who anticipate rejection or feel exposed when discussing relationships.
Group work is common in manualized MBT, but the available programs differ in frequency, duration, eligibility, and delivery. The presence of a group component does not itself establish efficacy, and a treatment package should be evaluated in the form in which it was studied. A randomized trial of group MBT for adolescents, for instance, did not find better primary outcomes than treatment as usual. Beck et al., 2020.
A therapist's curious, collaborative stance
MBT therapists commonly use what training materials call a 'not-knowing' stance: the therapist remains genuinely curious about the person's subjective experience and avoids pretending to know exactly what someone else intended. This stance is active rather than passive. Therapists ask clarifying questions, identify possible misunderstandings, name emotional shifts, and work jointly to examine them. The intent is to model a process of thoughtful inquiry that the person can increasingly apply outside therapy.
A practical example of an MBT intervention
A patient says, 'My partner looked away while I was talking, so I knew they wanted to leave me.' The therapist might ask what the patient noticed, what the moment felt like, and what evidence supported the conclusion. They might explore whether the partner had been distracted, whether the patient had previously experienced abandonment, and whether another conversation is possible. The patient and therapist can then consider how the fear shaped the response. The example illustrates the intervention's logic; it is neither a diagnostic vignette nor evidence that any particular person's partner was innocent or at fault.
How is MBT structured, and how long does treatment last?
Traditional outpatient MBT has commonly involved individual and group work over approximately 12 to 18 months, with an introductory phase and coordinated treatment team. The influential 2009 outpatient trial tested an 18-month program. Other services and trials use shorter or adapted protocols. Treatment length should reflect the studied model, current difficulties, access, shared goals, and ongoing review; it should not be framed as an individual test of motivation or a universal requirement for recovery.
An especially informative randomized trial compared five months with fourteen months of MBT in 166 adults who had diagnosed or subthreshold BPD. At the primary follow-up, investigators found no statistically significant difference in BPD symptoms, functioning, quality of life, or severe self-harm between the two groups. This finding challenges assumptions that longer MBT is always better; it does not demonstrate that the durations are clinically equivalent for every person or presentation. Juul et al., 2023.
Availability also matters. Some people can access specialized programs with a full multidisciplinary team; others receive time-limited psychotherapy, combined care, or a referral pathway. When an ideal program is unavailable, a qualified clinician can discuss supported alternatives without leaving someone untreated. The treatment choice should account for feasibility, safety, therapeutic alliance, and personal preference.
Does MBT work for BPD? What clinical trials show
The fairest answer is that MBT has encouraging randomized evidence and remains a legitimate structured psychotherapy option for BPD, while its overall certainty, relative advantage over high-quality alternatives, and active mechanisms remain incompletely established. Trial results depend on the comparator: being better than minimal or poorly coordinated care is a different claim from outperforming another credible specialist psychotherapy. Outcomes also differ. A reduction in diagnostic symptoms does not automatically mean improved work participation, stable relationships, or better quality of life.
The 2009 outpatient trial: MBT versus structured clinical management
Bateman and Fonagy randomized 134 adults with BPD to 18 months of outpatient MBT or structured clinical management, an active, organized clinical approach. Patients in both groups improved. The MBT group experienced advantages on some measured outcomes, including several indicators of clinical severity and crisis-related service use. The comparison is valuable because the control condition offered substantial care rather than no treatment. Its findings support a potential specific benefit but should be interpreted alongside other trials with different therapists, sites, samples, and outcome measures. Bateman and Fonagy, 2009.
Long-term follow-up: reasons for hope and reasons for caution
An earlier partial-hospitalization MBT study yielded an eight-year follow-up in which several favorable clinical differences persisted relative to treatment as usual. That report supports the possibility of enduring benefit for some participants after an intensive program. It followed a small original sample and represents an early investigator-led cohort, so it cannot predict individual recovery or establish that MBT uniquely produces durable benefits. Bateman and Fonagy, 2008.
Cochrane review: psychotherapy helps, but the MBT-specific evidence is uncertain
The 2020 Cochrane review, covering 75 randomized trials of psychological therapies for BPD, found evidence favoring BPD-tailored psychotherapy over treatment as usual on important outcomes. It reported signals favoring MBT for self-harm and suicidality at the end of treatment, but rated those MBT-specific findings as low-certainty evidence. Its subgroup analyses did not establish that any one therapy consistently surpassed the others. Readers should therefore distinguish the broader evidence for structured psychotherapy from the narrower evidence for the effects of MBT itself.
The 2025 evidence review: 14 randomized trials, serious limitations
Jørgensen and colleagues identified 14 randomized trials of MBT for BPD in a review whose search extended through April 1, 2025. Some trials reported improvements in symptoms and interpersonal functioning; findings were mixed, and every included trial was rated at high risk of bias. Methodological concerns included attrition, imbalances in clinical attention, and investigator or therapist allegiance. Most research came from European settings and predominantly female samples, with limited information about severity, comorbidities, other demographic groups, and developmental stages. These findings make confident claims of universal efficacy or clear superiority scientifically premature. Jørgensen et al., 2025.
This distinction is relevant to people making care decisions. A treatment can have a clinically coherent model, substantial clinical experience, and supportive studies while still having significant uncertainty in controlled comparisons. The appropriate practical interpretation is to consider MBT among structured options, ask about the quality of the local program, monitor meaningful outcomes, and change the plan when progress is insufficient.
Adolescents: evidence cannot simply be imported from adult trials
In a trial involving 112 adolescents, group MBT did not outperform treatment as usual on the primary outcome at the end of treatment; both groups had the same mean primary score and comparable remission proportions. Retention was also a challenge in the MBT arm. This does not prove that no adolescent can benefit. It shows that adaptations for age, family involvement, delivery format, and service setting require their own controlled evaluation. Beck et al., 2020.
Does MBT reduce self-harm or suicidal behavior?
Self-harm and suicide-related outcomes are clinically important, and research has examined whether MBT reduces them. Some studies and the Cochrane synthesis report favorable signals for MBT compared with treatment as usual, but the certainty of those estimates is low. The five- versus fourteen-month trial did not identify a significant difference in severe self-harm between the two MBT durations. Trial measures also vary: suicidal thoughts, self-injury without suicidal intent, suicide attempts, and hospitalization are distinct outcomes and must be reported separately.
A diagnosis of BPD does not mean that a person self-harms or has suicidal thoughts. Where risk is present, it requires individualized assessment and a collaborative safety plan, including what to do if a crisis intensifies, who can offer immediate support, and how urgent services can be reached. MBT should be integrated with appropriate crisis care; regular sessions are not a replacement for emergency assessment. The NICE guideline recommends crisis plans and careful follow-up within coordinated treatment.
If someone is at immediate risk of acting on suicidal thoughts, has seriously injured themselves, or cannot stay safe, contact local emergency services or seek emergency medical care. In the United States, 988 provides 24-hour suicide and crisis support; clinical teams can help patients and families make a more specific plan for non-emergency deterioration.
How MBT compares with DBT, schema therapy, and other psychotherapy
MBT versus dialectical behavior therapy (DBT)
DBT and MBT are structured psychotherapies often considered for BPD, but they emphasize different processes. DBT commonly teaches explicit skills for mindfulness, emotion regulation, distress tolerance, and interpersonal effectiveness, whereas MBT concentrates on restoring curiosity and understanding about mental states during emotionally charged relationships. These descriptions outline clinical emphases, not exclusive ingredients: effective therapy of either type may include emotional awareness, behavioral change, and collaborative reflection.
Current research does not establish a consistent overall winner between MBT and DBT. Different trials have different comparators, structures, participant profiles, fidelity, and outcomes, and reliable head-to-head comparisons remain limited. Storebø et al., 2020 and Jørgensen et al., 2025 support discussing both as potential structured options while considering local expertise, accessibility, the person's preferences, and the treatment targets.
MBT versus schema therapy and transference-focused psychotherapy
Schema therapy often works with enduring patterns of emotional needs, schemas, and coping modes. Transference-focused psychotherapy attends closely to representations of self and others as they emerge in the therapeutic relationship. MBT gives central importance to the process of interpreting mental states under changing levels of emotional arousal. Their theoretical distinctions can help patients understand the experience of each modality. Comparative superiority across all BPD presentations has not been established by the available evidence; specific therapist competence and a coherent care program remain important.
What about general supportive psychotherapy?
Well-delivered structured clinical management, collaborative case formulation, crisis planning, and ongoing professional support can themselves contribute to improvement. In the 2009 MBT trial, participants receiving structured clinical management also improved. This is a reminder that the control condition in a good psychotherapy study may be an active and useful treatment, and that treatment setting and patient engagement can matter as much as a model's name.
Who might benefit from MBT, and what should clinicians assess?
MBT may be a reasonable consideration for someone with clinically assessed BPD whose distress is especially visible in relationships, emotional misinterpretation, shifts in trust, or a sense of being overwhelmed during interpersonal conflict. The fit is assessed through actual clinical needs rather than a stereotype about BPD. Clinicians should consider current distress, capacity for participation, access to individual or group care, prior therapy experiences, treatment preferences, co-occurring diagnoses, safety, and practical obstacles such as scheduling and transportation.
Some people have PTSD, major depression, substance-use disorders, eating disorders, ADHD, autism, or other conditions alongside BPD. These require careful assessment on their own terms. The presence of trauma or neurodivergence does not establish BPD, and diagnostic overlap should be evaluated longitudinally. Treatment plans may need coordinated or sequenced interventions, adjustments for communication, and attention to physical health or medication. NICE CG78 explicitly calls for reviewing comorbid conditions and previous treatment response.
People with psychotic symptoms, acute mania, severe substance withdrawal, medical instability, or immediate safety concerns may first need evaluation and stabilization appropriate to that condition. Afterward, a clinician can assess when and how psychotherapy can proceed. Suitability is a matter of timing, resources, risk management, and individualized formulation, rather than an automatic exclusion based on one diagnostic label.
How is progress measured during treatment?
A meaningful review tracks more than whether the person can explain a mentalizing concept. Clinicians may assess the frequency and intensity of emotionally destabilizing episodes, the ability to pause during conflict, consistency of daily functioning, relationships, work or education participation, subjective well-being, crisis-service use, and self-harm when relevant. Measures of BPD symptom severity are useful when interpreted as repeated clinical indicators rather than substitutes for judgment.
The DSM-5-TR's categorical BPD diagnosis and ICD-11's severity-oriented personality-disorder framework provide different ways of describing clinical presentations. In dimensional assessment, clinicians may consider enduring difficulties in identity, self-direction, empathy, and intimacy along with broader functioning. A successful course of MBT would ideally improve everyday capacities and agency, regardless of whether a symptom score crosses a diagnostic threshold. Existing MBT research has focused heavily on symptom scores, and Jørgensen et al. call for stronger evaluation of core personality functioning and diverse life outcomes.
What are the limitations, burdens, and possible risks of MBT?
MBT asks people to revisit stressful relationships, reflect on emotionally loaded interactions, and sometimes participate in a group. Discussion may temporarily increase distress, shame, anger, or uncertainty. The treatment may also require sustained attendance and coordination across clinicians. People have different tolerances for group formats, self-disclosure, and interpersonal exploration; pacing and informed choice are part of responsible care.
Trials often underreport adverse events or use definitions that make comparison difficult. The 2023 duration trial observed more serious adverse events in the longer-duration group, but the difference was not statistically significant and was mainly related to psychiatric hospitalizations; the finding warrants monitoring rather than a causal conclusion that additional MBT caused harm. Therapeutic alliance ruptures, worsening symptoms, or increasing crises should be discussed and addressed promptly.
The research base also has structural limits. Participants and services in European specialist settings do not necessarily represent the full diversity of U.S. patients, rural services, older adults, men, gender-diverse populations, people with complex comorbidity, or people with limited access to care. Blinding participants or therapists to psychotherapy type is intrinsically difficult. Allegiance and treatment fidelity need attention. Jørgensen et al., 2025.
Remote-delivered or abbreviated adaptations may broaden access, but changing delivery format or intensity changes the treatment package. Claims about telehealth MBT or digital substitutes should be supported by trials of those specific approaches, especially when treatment is used in higher-risk clinical populations. General-purpose AI chatbots should not be described as providing clinician-delivered MBT without an appropriately evaluated clinical system and human safety oversight.
How to find a qualified MBT program
A good first step is to ask a licensed mental health professional who evaluates and treats personality disorders about available structured psychotherapy programs. Specialist clinics, hospital outpatient services, community mental health teams, and professional referral pathways may help. Availability varies by region, insurance coverage, and treatment setting. The clinical program's actual supervision, team organization, and crisis arrangements deserve as much attention as its promotional description.
Questions worth asking include: What formal MBT training and ongoing supervision do the clinicians have? Is the offered treatment individual, group-based, or combined? How long is the program and why? How do clinicians handle missed sessions, emergencies, or increased risk? How will functional progress be evaluated? What adaptations are available for accessibility, culture, language, trauma history, or co-occurring conditions? Can a patient discuss other structured treatments before committing? The NICE recommendations specifically emphasize informed choice, an integrated clinical approach, and supervision.
If progress is limited, a collaborative review can examine whether the treatment focus is appropriate, whether the relationship with the therapist feels workable, whether important co-occurring conditions are undertreated, and whether a different intensity or modality would better match current needs. An ineffective fit is a clinical planning issue to examine, not a personal failure.
Frequently asked questions about MBT for BPD
Is MBT a first-line treatment for borderline personality disorder?
MBT is one of several structured psychotherapies with relevant clinical research. The 2024 APA guideline recommends a supported structured psychotherapy that targets the core features of BPD and is selected collaboratively. It does not establish that every patient should start with MBT or that MBT consistently outperforms DBT and other credible interventions.
Is mentalization the same as mindfulness?
Both can involve attention to current experience, but mentalizing particularly concerns understanding behavior through possible thoughts, feelings, intentions, and beliefs in oneself and other people. Mindfulness often emphasizes observing present-moment experience. An MBT therapist may ask the person to notice feelings before considering what an interaction meant, yet the broader therapeutic task remains interpersonal understanding under uncertainty.
Can MBT help someone who has trouble trusting people?
Difficulty trusting others may be a relevant treatment concern, especially when rapid judgments about other people's motives cause repeated distress. MBT can provide a structured context for exploring assumptions, emotional reactions, and relational repair. Distrust alone is not diagnostic of BPD, and trust should develop in response to actual trustworthy behavior and a safe therapeutic relationship; MBT should never be used to persuade someone to ignore real mistreatment.
Does MBT require both individual and group therapy?
Many well-studied outpatient MBT programs include both, but services use variations and the choice should reflect the package's supporting evidence. Ask exactly what the local program offers. Evidence from a combined program cannot automatically be applied to group-only, individual-only, or self-guided treatment.
How many months until MBT starts helping?
There is no validated universal timetable for an individual. Traditional programs are commonly longer-term, while a randomized five-versus-fourteen-month comparison found no clear group-level advantage of the longer duration. Meaningful treatment reviews should occur along the way; the absence of immediate symptom change does not by itself determine the outcome, and continued deterioration deserves attention.
Is MBT better than DBT for suicidal behavior or self-harm?
The current evidence does not support a universal ranking of MBT above DBT on these outcomes. The Cochrane review found low-certainty MBT-specific evidence for some crisis-related outcomes and benefits of several structured treatments. The most appropriate care depends on current risk, available services, patient preferences, and the clinician's assessment; acute safety needs require their own plan.
Can MBT be used without a formal BPD diagnosis?
Mentalizing skills are relevant across ordinary relationships and clinical conditions, and MBT has been studied in additional populations. However, findings from BPD-specific trials establish evidence only for the studied participants and treatment packages. A clinician can discuss other uses with transparent information about what has been evaluated. No one should infer a diagnosis from perceived mentalizing difficulties.
Do people need medication while receiving MBT?
MBT is a psychological treatment. Medication may be indicated for certain co-occurring conditions, but no medication is established as a treatment for the core condition of BPD itself. The APA guideline suggests that psychotropic medications used in the treatment of BPD be time-limited, linked to a specific measurable target, and adjunctive to psychotherapy. A prescribing clinician should review benefits, risks, other diagnoses, and prior treatment; patients should not change medication without medical guidance.
What if group sessions make anxiety or shame worse?
Tell the treatment team. Clinicians can evaluate whether the distress reflects a manageable, therapeutically useful challenge, a problem with group boundaries, an accessibility barrier, a mismatch of treatment intensity, or a concerning worsening of symptoms. An informed plan may involve additional preparation, changes in pacing, parallel individual care, or a different program. Group participation should occur within an environment with clear boundaries and professional responsibility.
Can MBT repair a relationship or change another person's behavior?
MBT helps a person examine and respond to interpersonal experiences more flexibly; it cannot guarantee the decisions of a partner, friend, parent, or colleague. Reflective understanding may support clearer communication and personal boundaries. When coercion, violence, or exploitation is occurring, safety and realistic assessment of others' behavior take priority over reinterpretation.
What the evidence means for patients and clinicians
MBT offers a coherent way to work with episodes of intense emotional and interpersonal uncertainty. Its value is most accurately understood as one credible structured treatment option whose effectiveness should be assessed in the context of individual goals, available expertise, safety planning, and progress over time. Research findings justify clinical interest and ongoing study; they also require transparency about mixed comparisons, biased trials, underrepresented populations, and uncertainties about mechanism.
The most useful treatment question is not whether MBT has the most persuasive theory. It is whether the person has access to a qualified, supervised, appropriately structured program; whether the treatment matches current needs; and whether changes in symptoms, relationships, and everyday functioning are visible and meaningful. A person with BPD can improve, make new choices, and develop more satisfying relationships, and treatment should support that possibility without promising a uniform path.
Related Articles
For diagnostic context, read Borderline Personality Disorder: Symptoms, Diagnosis, and Treatment. For a broader comparison of supported modalities, see Psychotherapy for Personality Disorders: Treatments and Evidence. For interpersonal patterns and practical support, see Borderline Personality Disorder and Relationships: Patterns and Support.
References
Bateman, A., & Fonagy, P. (2008). 8-year follow-up of patients treated for borderline personality disorder: Mentalization-based treatment versus treatment as usual. American Journal of Psychiatry, 165(5), 631–638. https://doi.org/10.1176/appi.ajp.2007.07040636
Bateman, A., & Fonagy, P. (2009). Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder. American Journal of Psychiatry, 166(12), 1355–1364. https://doi.org/10.1176/appi.ajp.2009.09040539
Beck, E., Bo, S., Jørgensen, M. S., et al. (2020). Mentalization-based treatment in groups for adolescents with borderline personality disorder: A randomized controlled trial. Journal of Child Psychology and Psychiatry, 61(5), 594–604. https://doi.org/10.1111/jcpp.13152
Jørgensen, M. S., et al. (2025). Mentalization-based therapy for borderline personality disorder: State-of-the-science and future directions. Clinical Psychology & Psychotherapy. https://doi.org/10.1002/cpp.70120
Juul, S., et al. (2023). Short-term versus long-term mentalization-based therapy for borderline personality disorder: A randomized clinical trial (MBT-RCT). Psychotherapy and Psychosomatics, 92(5), 329–339. https://doi.org/10.1159/000534289
Keepers, G. A., et al. (2024). The American Psychiatric Association practice guideline for the treatment of patients with borderline personality disorder. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.24181010
National Institute for Health and Care Excellence. (2009, current online guidance). Borderline personality disorder: Recognition and management (CG78), Recommendations. https://www.nice.org.uk/guidance/cg78/chapter/Recommendations
Storebø, O. J., et al. (2020). Psychological therapies for people with borderline personality disorder. Cochrane Database of Systematic Reviews, 2020(5), CD012955. https://doi.org/10.1002/14651858.CD012955.pub2
Vogt, K. S., & Norman, P. (2019). Is mentalization-based therapy effective in treating the symptoms of borderline personality disorder? A systematic review. Psychology and Psychotherapy: Theory, Research and Practice, 92(4), 441–464. https://doi.org/10.1111/papt.12194